🇺🇸 FDA
Patent

US 10570418

Methods and compositions for RNA-directed target DNA modification

granted A61KA61K31/165A61K48/00

Quick answer

US patent 10570418 (Methods and compositions for RNA-directed target DNA modification) held by The Regents of the University of California expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/165, A61K48/00